Free Trial
NASDAQ:BIOL

BIOLASE (BIOL) Stock Price, News & Analysis

BIOLASE logo

About BIOLASE Stock (NASDAQ:BIOL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.0010
$0.0125
52-Week Range
N/A
Volume
517 shs
Average Volume
2.58 million shs
Market Capitalization
$581 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.20
Consensus Rating
Buy

Company Overview

Receive BIOL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BIOLASE and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BIOL Stock News Headlines

Biolase Inc (BIOLQ)
Biolase Inc. Faces Bankruptcy Amid Strategic Asset Sale
Missed the Last 10,000% Surge? Here’s Your Next Chance
Axcelis Technologies went from $2.50 to $180—a staggering 7,100% return. These are the kinds of small-cap breakouts Fierce Analyst aims to catch before they go mainstream. Our research team uses data and trend analysis to uncover high-potential stocks early. And now, you can get free alerts on the next set of breakout candidates—before the crowd rushes in.tc pixel
Sonendo, Inc. Reports Third Quarter 2024 Financial Results
See More Headlines

BIOL Stock Analysis - Frequently Asked Questions

BIOLASE, Inc. (NASDAQ:BIOL) announced its quarterly earnings results on Wednesday, November, 10th. The medical technology company reported ($50.00) earnings per share (EPS) for the quarter, beating the consensus estimate of ($75.00) by $25.00. The medical technology company earned $9.53 million during the quarter. BIOLASE had a negative trailing twelve-month return on equity of 1,782.73% and a negative net margin of 41.65%.

BIOLASE shares reverse split on the morning of Friday, July 28th 2023.The 1-100 reverse split was announced on Friday, July 28th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Shares of BIOL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BIOLASE investors own include Bionano Genomics (BNGO), Tonix Pharmaceuticals (TNXP), SNDL (SNDL), Zomedica (ZOM), NIO (NIO), Exela Technologies (XELA) and Ocugen (OCGN).

Company Calendar

Last Earnings
11/10/2021
Today
8/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Dental equipment & supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BIOL
Previous Symbol
NASDAQ:BLTI
CIK
811240
Employees
160
Year Founded
1987

Price Target and Rating

High Price Target
$2.00
Low Price Target
$0.40
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($14.94)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.63 million
Net Margins
-41.65%
Pretax Margin
-41.56%
Return on Equity
-1,782.73%
Return on Assets
-55.31%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.71
Quick Ratio
0.36

Sales & Book Value

Annual Sales
$48.83 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.07) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
33,407,000
Free Float
33,317,000
Market Cap
$581 thousand
Optionable
Not Optionable
Beta
0.67

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:BIOL) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners